Talaris Therapeutics, Inc. Contracts & Agreements

44 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended Non-Employee Director Compensation Policy
Compensation Agreements
Talaris Therapeutics, Inc.
Biotechnology
2025
Confirmatory offer letter, by and between the Registrant and Ryan Robinson, dated June 25, 2024
Talaris Therapeutics, Inc.
Biotechnology
2024
Amended Non-Employee Director Compensation Policy
Compensation Agreements
Talaris Therapeutics, Inc.
Biotechnology
2024
Description of Securities
Talaris Therapeutics, Inc.
Biotechnology
2024
Underwriting Agreement, dated January 25, 2024, by and among the Company, Jefferies LLC, Piper Sandler & Co., Guggenheim Securities, LLC and Truist Securities, Inc
Underwriting Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2024
Side Letter, dated as of November 10, 2023, by and between the Registrant and Ryan Robinson
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of June 7, 2023, by and between Tourmaline Bio, Inc. and Ryan Robinson
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Sandeep Kulkarni, M.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Brad Middlekauff, M.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Susan Dana Jones, Ph.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Tourmaline Bio, Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tourmaline Bio, Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Forms of Restricted Stock Unit Grant Notice and Award Agreement under Tourmaline Bio, Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
2023
Tourmaline Bio, Inc. 2023 Employee Stock Purchase Plan
Stock Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Form of Indemnification Agreement between Tourmaline Bio, Inc. and each of its directors and executive officers
Indemnification Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Strategic Advisor Agreement, by and between the Registrant and Scott Requadt, dated May 26, 2023
Talaris Therapeutics, Inc.
Biotechnology
KY
2023
License Agreement by and between Tourmaline Bio, LLC and Lonza Sales AG, dated May 16, 2022
License Agreements
Talaris Therapeutics, Inc.
Biotechnology
2023
License Agreement by and between Tourmaline Bio, LLC and Pfizer Inc., dated May 3, 2022
License Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
2022 Equity Incentive Plan of Tourmaline Bio, Inc., and form of award agreements thereunder
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Form of Tourmaline Support Agreement
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Form of Lock-Up Agreement
Talaris Therapeutics, Inc.
Biotechnology
2023
Forms of Talaris Support Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Agreement and Plan of Merger, dated as of June 22, 2023, by and among Talaris Therapeutics, Inc., Terrain Merger Sub, Inc. and Tourmaline Bio, Inc
Merger Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Lease Agreement between the Registrant and the University of Louisville, dated as of November 1, 2018, as amended on
Lease Agreements
Talaris Therapeutics, Inc.
Biotechnology
KY
2023
Transition Agreement, by and between the Registrant and Suzanne T. Ildstad, dated August 13, 2022
Transition Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Description of Securities
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Non-Employee Director Compensation Policy
Compensation Agreements
Talaris Therapeutics, Inc.
Biotechnology
2021
Forms of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
2021 Employee Stock Purchase Plan
Stock Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
2021 Stock Option and Incentive Plan and form of award agreements thereunder
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Form of Underwriting Agreement
Underwriting Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2021
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of September 22, 2020
Investor Rights Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Specimen Common Stock Certificate
Stock Agreements
Talaris Therapeutics, Inc.
Biotechnology
2021
Second Amended and Restated 2018 Equity Incentive Plan, as amended, and form of award agreements thereunder
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Talaris Therapeutics, Inc.
Biotechnology
2021
Severance and Change in Control Plan
Change of Control Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Lease Agreement between the Registrant and the University of Louisville, dated as of November 1, 2018, as amended on July 1, 2019, February 1, 2020, and May 15, 2020
Lease Agreements
Talaris Therapeutics, Inc.
Biotechnology
KY
2021
Employment Agreement, by and between the Registrant and Scott Requadt, dated November 1, 2018
Employment Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Employment Agreement, by and between the Registrant and Suzanne T. Ildstad, dated November 1, 2018
Employment Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Offer Letter, by and between the Registrant and Nancy Krieger, dated November 1, 2018
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Offer Letter, by and between the Registrant and Michael Zdanowski, dated September 29, 2020
Talaris Therapeutics, Inc.
Biotechnology
2021
Offer Letter, by and between the Registrant and Mary Kay Fenton, as amended, dated January 21, 2021
Talaris Therapeutics, Inc.
Biotechnology
2021
Amended and Restated Exclusive License Agreement, by and between the Registrant and University of Louisville Research Foundation, Inc., dated October 31, 2018
License Agreements
Talaris Therapeutics, Inc.
Biotechnology
KY
2021
Deferred Compensation Plan for Non-Employee Directors of the Registrant
Compensation Agreements
Talaris Therapeutics, Inc.
Biotechnology
2021